
TY  - JOUR
TI  - Poster Presentations
JO  - The FEBS Journal
VL  - 279
IS  - s1
SN  - 1742-464X
UR  - https://doi.org/10.1111/j.1742-4658.2010.08705.x
DO  - doi:10.1111/j.1742-4658.2010.08705.x
SP  - 52
EP  - 576
PY  - 2012
ER  - 

TY  - JOUR
TI  - 33rd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
VL  - 15
IS  - 3
SN  - 0906-6705
UR  - https://doi.org/10.1111/j.1600-0625.2006.00403.x
DO  - doi:10.1111/j.1600-0625.2006.00403.x
SP  - 187
EP  - 257
PY  - 2006
ER  - 

TY  - JOUR
TI  - Scientific Program
JO  - American Journal of Transplantation
VL  - 5
IS  - s11
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6135.2005.program.x
DO  - doi:10.1111/j.1600-6135.2005.program.x
SP  - 48
EP  - 153
PY  - 2005
ER  - 

TY  - JOUR
AU  - Mayo, Lior
AU  - Quintana, Francisco J.
AU  - Weiner, Howard L.
TI  - The innate immune system in demyelinating disease
JO  - Immunological Reviews
VL  - 248
IS  - 1
SN  - 0105-2896
UR  - https://doi.org/10.1111/j.1600-065X.2012.01135.x
DO  - doi:10.1111/j.1600-065X.2012.01135.x
SP  - 170
EP  - 187
KW  - innate immunity
KW  - astrocyte
KW  - demyelination
KW  - multiple sclerosis
KW  - central nervous system
PY  - 2012
AB  - Summary:? Demyelinating diseases such as multiple sclerosis are chronic inflammatory autoimmune diseases with a heterogeneous clinical presentation and course. Both the adaptive and the innate immune systems have been suggested to contribute to their pathogenesis and recovery. In this review, we discuss the role of the innate immune system in mediating demyelinating diseases. In particular, we provide an overview of the anti-inflammatory or pro-inflammatory functions of dendritic cells, mast cells, natural killer (NK) cells, NK-T cells, ?δ T cells, microglial cells, and astrocytes. We emphasize the interaction of astroctyes with the immune system and how this interaction relates to the demyelinating pathologies. Given the pivotal role of the innate immune system, it is possible that targeting these cells may provide an effective therapeutic approach for demyelinating diseases.
ER  - 

TY  - JOUR
TI  - TSANZ Abstracts
JO  - Respirology
VL  - 11
IS  - s2
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2006.821_2.x
DO  - doi:10.1111/j.1440-1843.2006.821_2.x
SP  - A7
EP  - A25
PY  - 2006
ER  - 

TY  - JOUR
TI  - Poster Discussion Session PDS 1
JO  - Allergy
JA  - Allergy
VL  - 70
IS  - S101
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12717
DO  - doi:10.1111/all.12717
SP  - 113
EP  - 279
PY  - 2015
ER  - 

TY  - JOUR
TI  - 35th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
VL  - 17
IS  - 3
SN  - 0906-6705
UR  - https://doi.org/10.1111/j.1600-0625.2007.00679.x
DO  - doi:10.1111/j.1600-0625.2007.00679.x
SP  - 241
EP  - 290
PY  - 2008
ER  - 

C7  - pp. 23-133
TI  - Cell surface and secreted proteins
SN  - 9781118849859
UR  - https://doi.org/10.1002/9781118849842.ch3
DO  - doi:10.1002/9781118849842.ch3
SP  - 23-133
KW  - adhesion molecules
KW  - ATP-binding cassette
KW  - cell surface
KW  - cytokines
KW  - GPCRs
KW  - host defence molecules
KW  - NHRS
KW  - secreted proteins
KW  - transporters
PY  - 2008
AB  - Summary This chapter includes HGNC entries for proteins that are expressed on the cell surface, namely receptors for different ligand classes, transporters and ion channels. Targets for existing drugs are strongly over-represented in this group; for example, approximately 40% of current medicines affect G-protein-coupled receptors (GPCRs), and hundreds of these molecules are listed with annotations that indicate pharmaceutical potential. The chapter also discusses targets that involve protein-protein or protein-carbohydrate interactions. These are cytokines and their receptors, adhesion molecules and host defence molecules; the allocation of entries in these three sections is less clear-cut than with the GPCRs. The last group of entries that is discussed is the transporters and channels. The ATP-binding cassette and solute carrier families are not only primary therapeutic targets but also contain proteins that contribute to drug resistance.
ER  - 

TY  - JOUR
TI  - Day at a Glance
JO  - American Journal of Transplantation
VL  - 4
IS  - s8
SN  - 9781118849859
UR  - https://doi.org/10.1111/j.1600-6135.2004.00492.x
DO  - doi:10.1111/j.1600-6135.2004.00492.x
SP  - 51
EP  - 159
PY  - 2004
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 109
IS  - S1
SN  - 9781118849859
UR  - https://doi.org/10.1111/vox.12304
DO  - doi:10.1111/vox.12304
SP  - 1
EP  - 379
PY  - 2015
ER  - 

TY  - JOUR
TI  - British Society for Matrix Biology – Spring 2012 Meeting Report
JO  - International Journal of Experimental Pathology
JA  - Int. J. Exp. Path.
VL  - 94
IS  - 1
SN  - 9781118849859
UR  - https://doi.org/10.1111/iep.12004
DO  - doi:10.1111/iep.12004
SP  - A1
EP  - A48
PY  - 2013
ER  - 

TY  - JOUR
TI  - Friday, 14 June 2002
JO  - Contact Dermatitis
VL  - 46
IS  - s4
SN  - 9781118849859
UR  - https://doi.org/10.1034/j.1600-0536.46.s4.32.x
DO  - doi:10.1034/j.1600-0536.46.s4.32.x
SP  - 5
EP  - 22
PY  - 2002
ER  - 

TY  - JOUR
TI  - Sunday, 16 June 2002
JO  - Contact Dermatitis
VL  - 46
IS  - s4
SN  - 9781118849859
UR  - https://doi.org/10.1034/j.1600-0536.46.s4.34.x
DO  - doi:10.1034/j.1600-0536.46.s4.34.x
SP  - 32
EP  - 40
PY  - 2002
ER  - 

TY  - JOUR
TI  - 19th Annual Symposium on Nonhuman Primate Models for AIDS:
JO  - Journal of Medical Primatology
VL  - 31
IS  - 4‐5
SN  - 9781118849859
UR  - https://doi.org/10.1034/j.1600-0684.2002.02011.x
DO  - doi:10.1034/j.1600-0684.2002.02011.x
SP  - 258
EP  - 309
PY  - 2002
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 21
IS  - S1
SN  - 9781118849859
UR  - https://doi.org/10.1111/1756-185X.13361
DO  - doi:10.1111/1756-185X.13361
SP  - 23
EP  - 236
PY  - 2018
ER  - 

TY  - JOUR
TI  - Saturday, 15 June 2002
JO  - Contact Dermatitis
VL  - 46
IS  - s4
SN  - 9781118849859
UR  - https://doi.org/10.1034/j.1600-0536.46.s4.33.x
DO  - doi:10.1034/j.1600-0536.46.s4.33.x
SP  - 22
EP  - 32
PY  - 2002
ER  - 

TY  - JOUR
TI  - XXII International Pigment Cell Conference (IPCC) “Bringing Colors to Life: Advances in Pigment Cell Research and Translation into Clinical Practice” Organised by the Asian Society for Pigment Cell Research (ASPCR), in partnership with the Dermatological Society of Singapore (DSS)
JO  - Pigment Cell & Melanoma Research
JA  - Pigment Cell Melanoma Res.
VL  - 27
IS  - 5
SN  - 9781118849859
UR  - https://doi.org/10.1111/pcmr.12292
DO  - doi:10.1111/pcmr.12292
SP  - 849
EP  - 1001
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts - Tuesday 24th July 2001
JO  - Scandinavian Journal of Immunology
VL  - 54
IS  - s1
SN  - 9781118849859
UR  - https://doi.org/10.1046/j.1365-3083.2001.0540s1002.x
DO  - doi:10.1046/j.1365-3083.2001.0540s1002.x
SP  - 2
EP  - 2
PY  - 2001
ER  - 

TY  - JOUR
TI  - Primary Immunodeficiency Diseases Report of an IUIS Scientific Committee
JO  - Clinical & Experimental Immunology
JA  - Clinical & Experimental Immunology
VL  - 118
IS  - S1
SN  - 9781118849859
UR  - https://doi.org/10.1046/j.1365-2249.1999.00109.x
DO  - doi:10.1046/j.1365-2249.1999.00109.x
SP  - 1
EP  - 28
PY  - 1999
ER  - 

TY  - JOUR
TI  - ASBMR 31st Annual Meeting SU0001–SU0466
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 24
IS  - S1
SN  - 9781118849859
UR  - https://doi.org/10.1002/jbmr.5650241304
DO  - doi:10.1002/jbmr.5650241304
SP  - S237
EP  - S369
PY  - 2009
ER  - 
